[HTML][HTML] Treatment with inhaled corticosteroids in chronic obstructive pulmonary disease
C Janson - Journal of Thoracic Disease, 2020 - ncbi.nlm.nih.gov
In chronic obstructive pulmonary disease (COPD), treatment with inhaled corticosteroids
(ICSs) in combination with long acting beta-2-agonists (LABA) or LABA/long-acting …
(ICSs) in combination with long acting beta-2-agonists (LABA) or LABA/long-acting …
Chronic obstructive pulmonary disease: moving from symptom relief to mortality reduction
A Celi, M Latorre, P Paggiaro… - Therapeutic Advances in …, 2021 - journals.sagepub.com
Chronic obstructive pulmonary disease (COPD) has a 3-year mortality rate up to 37%, 2–6
times higher than the general population. We present evidence supporting pharmacological …
times higher than the general population. We present evidence supporting pharmacological …
Triple therapy trials in COPD: a precision medicine opportunity
S Suissa, A Ariel - European Respiratory Journal, 2018 - Eur Respiratory Soc
The Global Initiative for Chronic Obstructive Lung Disease (GOLD) strategy document for the
treatment of chronic obstructive pulmonary disease (COPD) suggests that, after …
treatment of chronic obstructive pulmonary disease (COPD) suggests that, after …
Outcomes for COPD pharmacological trials: from lung function to biomarkers
M Cazzola, W MacNee, FJ Martinez… - European respiratory …, 2008 - Eur Respiratory Soc
The American Thoracic Society/European Respiratory Society jointly created a Task Force
on “Outcomes for COPD pharmacological trials: from lung function to biomarkers” to inform …
on “Outcomes for COPD pharmacological trials: from lung function to biomarkers” to inform …
Blood eosinophil counts in clinical trials for chronic obstructive pulmonary disease
D Singh, M Bafadhel, CE Brightling… - American journal of …, 2020 - atsjournals.org
Chronic obstructive pulmonary disease (COPD) is a complex condition with pathophysiology
and clinical characteristics that vary in presence and severity between patients (1). This …
and clinical characteristics that vary in presence and severity between patients (1). This …
Pharmacotherapy of chronic obstructive pulmonary disease: a clinical review
B Antus - International Scholarly Research Notices, 2013 - Wiley Online Library
Chronic obstructive pulmonary disease (COPD) is one of the leading causes of mortality and
morbidity worldwide. In addition to generating high healthcare costs, COPD imposes a …
morbidity worldwide. In addition to generating high healthcare costs, COPD imposes a …
Canadian Thoracic Society Clinical Practice Guideline on pharmacotherapy in patients with COPD–2019 update of evidence
In this guideline update, we highlight important and new findings related to pharmacological
therapy of chronic obstructive pulmonary disease (COPD) that should change clinical …
therapy of chronic obstructive pulmonary disease (COPD) that should change clinical …
Positioning new pharmacotherapies for COPD
IZ Barjaktarevic, AF Arredondo… - International journal of …, 2015 - Taylor & Francis
COPD imposes considerable worldwide burden in terms of morbidity and mortality. In
recognition of this, there is now extensive focus on early diagnosis, secondary prevention …
recognition of this, there is now extensive focus on early diagnosis, secondary prevention …
Comparative effectiveness of triple therapy versus dual bronchodilation in COPD
J Voorham, M Corradi, A Papi… - ERJ Open …, 2019 - Eur Respiratory Soc
This real-world study compared the effectiveness of triple therapy (TT; long-acting
muscarinic antagonists (LAMAs)/long-acting inhaled β-agonists (LABAs)/inhaled …
muscarinic antagonists (LAMAs)/long-acting inhaled β-agonists (LABAs)/inhaled …
Recent updates in chronic obstructive pulmonary disease
C Garvey - Postgraduate medicine, 2016 - Taylor & Francis
Chronic obstructive pulmonary disease (COPD), characterized by chronic airways
inflammation and progressive airflow limitation, is a common, preventable and treatable …
inflammation and progressive airflow limitation, is a common, preventable and treatable …